Literature DB >> 16010872

Detection of nimesulide metabolites in rat plasma and hepatic subcellular fractions by HPLC-UV/DAD and LC-MS/MS studies.

S Güniz Küçükgüzel1, Ilkay Küçükgüzel, Başak Oral, Sena Sezen, Sevim Rollas.   

Abstract

Nimesulide (4-nitro-2-phenoxymethanesulfonanilide) is an atypical NSAID lacking a carboxylic acid moiety. It has a good gastric tolerability due to selective inhibition of COX-2. The study objectives in the present work were to characterize the metabolism of nimesulide in rat plasma at certain time intervals. In vitro studies were also carried out to examine if nitroreduction takes place in vitro using rat hepatic subcellular fractions (microsomal and S9 fraction) besides aromatic hydroxylation. This communication describes detection and characterization of nimesulide metabolites isolated from plasma and hepatic subcellular post-incubates by the use of HPLC-UV/diode array and LC-MS/MS. Hydroxynimesulide was the major metabolite both in vivo and in vitro whereas nitroreduction was observed only in vitro with subcellular fractions under anaerobic conditions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16010872     DOI: 10.1007/BF03226418

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  20 in total

1.  Simultaneous determination of nimesulide and hydroxynimesulide in rat plasma, cerebrospinal fluid and brain by liquid chromatography using solid-phase extraction.

Authors:  Paolo Ferrario; Mauro Bianchi
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2003-03-05       Impact factor: 3.205

2.  Inhibition of neutrophil oxidative metabolism by nimesulide.

Authors:  F Capsoni; E Venegoni; F Minonzio; A M Ongari; V Maresca; C Zanussi
Journal:  Agents Actions       Date:  1987-06

3.  Mass spectrometric characterization and HPLC determination of the main urinary metabolites of nimesulide in man.

Authors:  M Carini; G Aldini; R Stefani; C Marinello; R M Facino
Journal:  J Pharm Biomed Anal       Date:  1998-10       Impact factor: 3.935

4.  Synthesis, metabolism and structure-mutagenicity relationships of novel 4-nitro-(imidazoles and pyrazoles) in Salmonella typhimurium.

Authors:  P Hrelia; C Fimognari; F Maffei; B Brighenti; L Garuti; S Burnelli; G Cantelli-Forti
Journal:  Mutat Res       Date:  1998-02-02       Impact factor: 2.433

5.  Determination of nimesulide and hydroxynimesulide in human plasma by high performance liquid chromatography.

Authors:  C Giachetti; A Tenconi
Journal:  Biomed Chromatogr       Date:  1998 Mar-Apr       Impact factor: 1.902

6.  Non-enzymatic reduction of azo dyes by NADH.

Authors:  S Nam; V Renganathan
Journal:  Chemosphere       Date:  2000-02       Impact factor: 7.086

7.  Nimesulide decreases superoxide production by inhibiting phosphodiesterase type IV.

Authors:  M Bevilacqua; T Vago; G Baldi; E Renesto; F Dallegri; G Norbiato
Journal:  Eur J Pharmacol       Date:  1994-08-16       Impact factor: 4.432

8.  Zomepirac acyl glucuronide covalently modifies tubulin in vitro and in vivo and inhibits its assembly in an in vitro system.

Authors:  M J Bailey; S Worrall; J de Jersey; R G Dickinson
Journal:  Chem Biol Interact       Date:  1998-09-04       Impact factor: 5.192

Review 9.  Mechanisms of NSAID-induced hepatotoxicity: focus on nimesulide.

Authors:  Urs A Boelsterli
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

10.  Rat serum albumin modified by diflunisal acyl glucuronide is immunogenic in rats.

Authors:  S Worrall; R G Dickinson
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

View more
  1 in total

1.  HPLC analysis of in vivo metabolites of 4-nitrobenzoic acid [(5-nitro-2-thiopheneyl)methylene]hydrazide in rats.

Authors:  Bedia Koçyiğit-Kaymakçioğlu; Seda Unsalan; S Güniz Küçükgüzel; Göksel Sener; Sevim Rollas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2007 Oct-Dec       Impact factor: 2.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.